Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Acta Biochim Pol ; 71: 12299, 2024.
Article de Anglais | MEDLINE | ID: mdl-38721302

RÉSUMÉ

This report describes a comprehensive approach to local random mutagenesis of the E. coli Ntn-amidohydrolase EcAIII, and supplements the results published earlier for the randomization series RDM1. Here, random mutagenesis was applied in the center of the EcAIII molecule, i.e., in the region important for substrate binding and its immediate neighborhood (series RDM2, RDM3, RDM7), in the vicinity of the catalytic threonine triplet (series RDM4, RDM5, RDM6), in the linker region (series RDM8), and in the sodium-binding (stabilization) loop (series RDM9). The results revealed that the majority of the new EcAIII variants have abolished or significantly reduced rate of autoprocessing, even if the mutation was not in a highly conserved sequence and structure regions. AlphaFold-predicted structures of the mutants suggest the role of selected residues in the positioning of the linker and stabilization of the scissile bond in precisely correct orientation, enabling the nucleophilic attack during the maturation process. The presented data highlight the details of EcAIII geometry that are important for the autoproteolytic maturation and for the catalytic mechanism in general, and can be treated as a guide for protein engineering experiments with other Ntn-hydrolases.


Sujet(s)
Amidohydrolases , Escherichia coli , Mutagenèse , Amidohydrolases/génétique , Amidohydrolases/métabolisme , Amidohydrolases/composition chimique , Escherichia coli/génétique , Protéines Escherichia coli/génétique , Protéines Escherichia coli/métabolisme , Protéines Escherichia coli/composition chimique , Modèles moléculaires , Séquence d'acides aminés , Mutation
2.
Molecules ; 29(10)2024 May 11.
Article de Anglais | MEDLINE | ID: mdl-38792133

RÉSUMÉ

L-asparaginases are used in the treatment of acute lymphoblastic leukemia. The aim of this work was to compare the antiproliferative potential and proapoptotic properties of novel L-asparaginases from different structural classes, viz. EcAIII and KpAIII (class 2), as well as ReAIV and ReAV (class 3). The EcAII (class 1) enzyme served as a reference. The proapoptotic and antiproliferative effects were tested using four human leukemia cell models: MOLT-4, RAJI, THP-1, and HL-60. The antiproliferative assay with the MOLT-4 cell line indicated the inhibitory properties of all tested L-asparaginases. The results from the THP-1 cell models showed a similar antiproliferative effect in the presence of EcAII, EcAIII, and KpAIII. In the case of HL-60 cells, the inhibition of proliferation was observed in the presence of EcAII and KpAIII, whereas the proliferation of RAJI cells was inhibited only by EcAII. The results of the proapoptotic assays showed individual effects of the enzymes toward specific cell lines, suggesting a selective (time-dependent and dose-dependent) action of the tested L-asparaginases. We have, thus, demonstrated that novel L-asparaginases, with a lower substrate affinity than EcAII, also exhibit significant antileukemic properties in vitro, which makes them interesting new drug candidates for the treatment of hematological malignancies. For all enzymes, the kinetic parameters (Km and kcat) and thermal stability (Tm) were determined. Structural and catalytic properties of L-asparaginases from different classes are also summarized.


Sujet(s)
Antinéoplasiques , Apoptose , Asparaginase , Prolifération cellulaire , Humains , Asparaginase/pharmacologie , Asparaginase/composition chimique , Asparaginase/métabolisme , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Spécificité du substrat , Cellules HL-60 , Leucémies/traitement médicamenteux , Leucémies/enzymologie
3.
Postepy Biochem ; 68(4): 410-424, 2022 12 31.
Article de Polonais | MEDLINE | ID: mdl-36649135

RÉSUMÉ

Linker histones (H1) are proteins found in the nuclei of the vast majority of Eucaryota, playing important roles in their life and development. H1 takes part in processes such as chromatin condensation, transcriptional regulation of gene expression, apoptosis induction and many more. Despite its common presence and essential function, many questions remain unanswered. Experiments conducted to date don't provide unambiguous information on such crucial issues as e.g. the way linker histones bind to nucleosome. There is also much surprising information about H1 participating in physiological processes not connected directly to its widely known function ­ e.g. providing a microtubule organization center in plants or contributing to the defense against pathogens in fish. The objective of the present work is to provide insights into many aspects of linker histone structure and function, collect and systematize current knowledge and to outline questions worth answering in the future.


Sujet(s)
Chromatine , Histone , Animaux , Histone/composition chimique , Chromatine/métabolisme , Nucléosomes/métabolisme , Noyau de la cellule/métabolisme , Régulation de l'expression des gènes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...